Showing results (21-30 of 175) with videos related to

Sort By:
Pageof 18
American Journal of Clinical Oncology|August 1, 1991
A phase II trial of gallium nitrate (NSC #15200) in previously treated ovarian carcinoma. A Gynecologic Oncology Group StudyJ H Malfetano, J A Blessing, M D Adelson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1989
Adverse effects of intraperitoneal fluorouracil in patients with optimal residual ovarian cancer after second-look laparotomy: a Gynecologic Oncology Group StudyL A Walton, J A Blessing, H D Homesley
Investigational New Drugs|November 1, 1989
Phase II study of esorubicin (4'-deoxydoxorubicin) in advanced epithelial carcinoma of the ovary: a Gynecologic Oncology Group studyW P McGuire, J A Blessing, M L Berman
American Journal of Clinical Oncology|February 1, 1993
A phase II trial of Didemnin B (NSC #335319) in patients with previously treated epithelial ovarian cancer. A Gynecologic Oncology Group StudyJ H Malfetano, J A Blessing, A J Jacobs
American Journal of Clinical Oncology|December 1, 1995
A phase II trial of gallium nitrate (NSC #15200) in nonsquamous cell carcinoma of the cervix. A Gynecologic Oncology Group studyJ H Malfetano, J A Blessing, H D Homesley
Investigational New Drugs|February 1, 1991
A phase II trial of diaziquone (AZQ) in mixed mesodermal sarcomas of the uterus. A Gynecologic Oncology Group studyR E Slayton, J A Blessing, D Clarke-Pearson
American Journal of Clinical Oncology|April 1, 1994
A Gynecologic Oncology Group phase II study of amonafide (NSC #308847) in squamous cell carcinoma of the cervixR F Asbury, J A Blessing, J T Soper
Investigational New Drugs|November 1, 1989
A phase II clinical trial of diaziquone (AZQ) in the treatment of patients with recurrent adenocarcinoma and adenosquamous carcinoma of the cervix. A Gynecologic Oncology Group studyR E Slayton, J A Blessing, M Rettenmaier, et al.
Investigational New Drugs|May 1, 1991
A phase II clinical trial of diaziquone (AZQ) in the treatment of patients with recurrent leiomyosarcoma of the uterus. A Gynecologic Oncology Group studyR E Slayton, J A Blessing, K Look, et al.
American Journal of Clinical Oncology|October 1, 1995
A phase II trial of merbarone (NSC 336628) as salvage therapy for squamous cell carcinoma of the cervix. A Gynecologic Oncology Group StudyK Y Look, J A Blessing, L Williams, et al.
Pageof 18